Why Authenticity And Patient Voice Are Critical When Driving Clinical Trial Diversity

Watch this on-demand webinar to explore strategies for enhancing clinical trial accessibility and representation within the pharmaceutical industry through increased diversity. While recent initiatives like the Food and Drug Omnibus Reform Act of 2022 (FDORA) and the FDA's draft guidance on diversity plans are a start, it remains essential for pharmaceutical and biotech companies to consider diversity initiatives early—even before recruitment begins.

In this session, a panel of experts—including a patient advocate, community organizer, and representatives from two leading pharmaceutical companies—discuss the importance of engaging local community leaders to build trust in specific clinical studies. Through two insightful case studies, the panel illustrates practical approaches to diversity, equity, and inclusion (DE&I) in trial recruitment and retention: the first case outlines a grassroots strategy that successfully recruited African American women for lupus studies, while the second highlights a video series amplifying diverse patient voices to inspire broader clinical trial participation.

Tune in to learn more about effective community engagement and the role of diverse patient narratives in advancing clinical trial diversity.